Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

The role of γδT-cells in causing alopecia areata remains unclear.

Targeting Vδ1+T-cells may help treat alopecia areata.

Special cells can help regrow hair in alopecia areata.

CD4+ skin cells may be precursors to basal cell carcinoma.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Targeting specific T cells may help treat alopecia areata.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Skin cells control immune cell placement, helping the skin respond better to challenges.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

IL-17 and certain immune cells are linked to more severe alopecia areata.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

IL-18 signaling helps mature Tregs move into the thymus.